Pain Management and Care Clinical Trial
Official title:
Contribution of the MEOPA in the Physiotherapy Care of Painful Articular Steepness Among Elderly
The MEOPA is used to obtain an analgesia of the short-term painful acts. To the population
of elderly patients, the therapeutic resources to control the passing pain require in their
manipulation a certain caution and are not divested of side effects badly tolerated at this
age. An alternative in the opioid presents all its interest. The MEOPA is here an
alternative of choice in the care of these pains, in particular in case of pre-existent
cognitive achievement, of polypathologies or of polymédication.
The gas MEOPA administered to the mask could thus be an effective additive in the
physiotherapy treatment of the elderly person.
The main objective is to Assess the efficacy , in terms of recovery of the hip and knee
joint articular amplitude, of 3 sessions of reeducation using MEOPA versus standard
reeducation within a population of elderly patients presenting a pain during the
physiotherapy treatment.
| Status | Recruiting |
| Enrollment | 64 |
| Est. completion date | July 2015 |
| Est. primary completion date | May 2015 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 65 Years and older |
| Eligibility |
Inclusion Criteria: - Male or female aged 65 years old or more - Patients having a prescription for physiotherapy - Absence of contraindication to MEOPA - Patients whose initial assessment show a passive articular deficit of at least a joint of hip or the knee and whose painful assessment is = 5 or = 2 during mobilisation on the validated scale Algoplus - Patients whose reeducation project established by the physiotherapist - Patients having agreed to participate in the study and having signed the consent - Subjects affiliated to the social security system Exclusion Criteria: - Patient requiring a ventilation in pure oxygen - Patient with a consciousness deterioration preventing his cooperation - Care under MEOPA during the period of the protocol and during the month which precedes - Increase of the dosage of morphine of less than 48 hours Patient under guardianship |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
| Country | Name | City | State |
|---|---|---|---|
| France | CHU de Nice | Nice | |
| France | Pôle de Gérontologie Hôpital de Cimiez CHU de Nice | Nice |
| Lead Sponsor | Collaborator |
|---|---|
| Centre Hospitalier Universitaire de Nice |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | % of recovery of the hip and knee joint articular amplitude | % of recovery of the hip and knee joint articular amplitude during 5 days after 3 sessions of reeducation using MEOPA versus standard reeducation within a population of elderly patients presenting a pain during the physiotherapy treatment; measure % of recovery of the hip and knee joint articular amplitude two times : before the beginning of the session of reeducation and at the end of the session | 5 days | Yes |
| Secondary | Measure of the pain | Patient answer a questionnaire on his pain at the beginning of each session of reeducation (5 sessions) | 5 days | No |
| Secondary | Patients'satisfaction | Patient answer a questionnaire on this satisfaction at the end of the period of care of the protocol. | End of the period of care (up to 5 days) | No |
| Secondary | Physiotherapists'satisfaction | Physiotherapists answer a questionnaire on this satisfaction of the use of the MEOPA | End of all the period of care (up to 5 days) | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06001749 -
Psilocybin in Cancer Pain Study
|
Phase 2 |